Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
cbd - search results
If you're not happy with the results, please do another search
Trochlear dysplasia: A common & confusing knee condition
Trochlear dysplasia is a common abnormality of the knee, a strict definition upon objective criteria and biomechanical studies is missing
Reversing destruction of biodiversity should be top priority
Over 50 experts say reversing biodiversity loss will take take more than placing protection on land and sea zones.
How can hemp compounds block the COVID-19 virus infection?
Research demonstrates the ability to prevent COVID-19 from entering human cells through cannabinoid acids binding to a SARS-CoV-2 protein, blocking infection from the virus.
Oils By Simpson™ – Cannabis Oil for better health
At OilsBySimpson we provide the highest quality of organic full-spectrum cannabis oil products, and the best customer service.
The three-step framework for biodiversity action
Scientists propose a three-step post-2020 framework for global biodiversity goals for governments to implement on a national level.
Machine identifies suicidal thoughts with 91% accuracy
Researchers have developed a new machine with a learning-based approach to recognise adolescents undergoing suicidal thoughts and behaviour.
TIGRR: Is it a wonderful thing for the UK’s Cannabis Industry?
BCL Solicitors LLP ask if a new report should put a spring in the step of UK businesses with an interest in medicinal cannabis and cannabidiol (CBD).
Can cannabidiol treat Type 2 diabetes?
Delve into the story of Kevin Simpson, who used Cannabidiol (CBD) to treat Type 2 Diabetes.
European regulatory environment acting as driver of fintech innovation
Susan Friedman, Head of Public Policy, Ripple, discusses how European regulation acts as a driver for fintech innovation.
High stakes: Is the UK finally clearing a pathway for cannabis investments?
John Binns, Partner at BCL Solicitors LLP says it’s high stakes when it comes to the UK finally clearing a pathway towards cannabis investments.
Ensuring regulatory compliance for Medical Cannabis
Here, Evolve Ltd’s Managing Director, Christopher Busuttil Delbridge, takes us progressively deeper into what it takes to ensure regulatory compliance for Medical Cannabis.
Will 2021 see the UK’s cannabis industry bloom?
John Binns & David Hardstaff from BCL Solicitors LLP, reveal if 2021 will be the year that sees the UK’s cannabis industry bloom.
Cannabis as a treatment for COVID-19
Kevin William Simpson, CEO and Founder of OilsBySimpson, tells us about the growing evidence around cannabis as a treatment for COVID-19.
The changing perspective of psychedelic drugs with a history of abuse
Jason W. Loxterkamp and Pamela J. Lein from University of California, Davis, explore the therapeutic potential of psychedelic drugs in patients with psychiatric disorders.
Cannabidiol, skin homeostasis and acne
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains the potential of CBD and cannabinoids for skin care.
The UK’s legalisation of medicinal cannabis
David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.
Medical cannabis in the UK and the industry’s future
Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry.
Kim Schleppegrell Skaue joins Oils By Simpson: Their mission to promote natural medicine
Read on to find out more about Oils By Simpson, Kim Schleppegrell Skaue, and their joint mission to encourage natural medicine use worldwide.
Functionality of Hemp Proteins and their Peptides
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains why hemp protein is gaining a reputation as nutraceutical product.
Why COVID might actually save the NHS
The rise of the virtual ward is charted here by Max Mckiernan, L2S2’s Marketing Manager and Jane Aldridge, Co-Founder/CBDO/CFO, including analysis of why COVID may save the NHS.
